HFA Premium Access

Moderated Poster session 3 - Novel treatment

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Chronic Heart Failure
Session type: Moderated Posters
Date: 27 May 2018
Time: 15:45 - 16:30

Congress Session

7 presentations in this session

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

Thumbnail

What proportion of patients with HFrEF might be candidates for Sacubitril-Valsartan?

Speaker: Doctor T. O connor (Dublin, IE)
Thumbnail

Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies

Speaker: Mrs M. Oyanguren Artola (Bilbao, ES)
Thumbnail

Metabolic response to exercise training in heart failure with preserved ejection fraction

Speaker: Doctor M. Bahls (Greifswald, DE)
Thumbnail

Adherence to ESC guidelines after hospital admission for heart failure in 22500 Dutch patients: 2001-2015

Speaker: Mrs W. Kruik-Kolloffel (Almelo, NL)
Thumbnail

Cardiovascular outcomes with the incretin-based therapies GLP-1 agonists and DPP-4 inhibitors in type 2 diabetes participants with and without heart failure

Speaker: Doctor S. Zheng (London, GB)
Thumbnail

Functional and anatomical pulmonary arterial disease in patients with persistent pulmonary hypertension after left valve replacement according to the hemodynamic phenotype

Speaker: Doctor E. Peris Domingo (Barcelona, ES)
Thumbnail

6 speakers from this session

Doctor Tim O connor

Beaumont Hospital, Dublin (Ireland)
1 presentation
0 follower

Mrs Maria Juana Oyanguren Artola

BIOCRUCES Health Research Institute, Bilbao (Spain)
1 presentation
0 follower

Doctor Martin Bahls

University Medicine of Greifswald, Greifswald (Germany)
0 follower

Mrs Willemien Kruik-Kolloffel

Twente Hospital Group, Almelo (Netherlands (The))
0 follower

Doctor Sean Zheng

King's College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Enrique Peris Domingo

University Hospital Vall d'Hebron, Barcelona (Spain)
0 follower

This platform is supported by

logo Novo Nordisk